LEF1 and prostate cancer: ETS-related gene (ERG) upregulates the downstream mediator transcription factor of the Wnt/β-catenin signaling pathway named Lymphoid enhancer-binding factor 1 (LEF1), which in turn enhances the androgen receptor expression and activity, leading to prostate cancer in an androgen-independent manner [77].